Cramer Says Pfizer (PFE) Should Buy Allergan (AGN)

On Mad Money tonight, Jim Cramer said Pfizer (NYSE: PFE) should really take a strong look at buying Allergan (NYSE: AGN). Cramer thinks this is a smart play similar to Johnson & Johnson buying out Mentor Corporation (NYSE: MNT) earlier in the week.

Both Allergan and Mentor produce products that are used in cosmetic surgeries.

Additionally, Cramer liked that Allergan has a strong growth rate, whereas Pfizer has no growth. Therefore, if Pfizer makes a play for Allergan, it would get that much needed growth the Street covets.

In today's trading, Allergan closed at $36.20 and currently in the after-hours it is at $35.18.

Allergan, Inc. is a multi-specialty healthcare company focused on developing and commercializing pharmaceuticals, biologics and medical devices.
Sign up at EasyStockAlerts.com To Be Alerted To Your Stock News!

You May Also Be Interested In

• Tuta Mail Files Google Complaint Under EU Tech Rules - Reuters
• Person covered in flames outside NY courthouse where Donald Trump's trial is held - CNN
• Tesla (TSLA) soars on Q1 print